TORONTO, Aug. 29 /CNW/ - Vasogen Inc. (NASDAQ:VSGN; TSX:VAS), a leader in
the research and commercial development of technologies targeting chronic
inflammation underlying cardiovascular and neurological disease, today
announced that it will host a conference call and a web cast slide
presentation on Tuesday, September 5th, at 8:30 a.m. Eastern Time, to discuss
new data from the ACCLAIM trial of its Celacade(TM) technology in patients
with advanced heart failure.
